23.01.2019
Protocol Extraordinary Annual Meeting January 23rd 2019
January 23rd 2019 Protocoll of Extraordinary Annual Meeting January 23rd 2019. The Extraordinary Annual Meeting 2019 took place in the Companys office, Karvesvingen. 2, Oslo
18.12.2018
New EPO Patent granted 2018
New EPO patent
10.12.2018
Eqology AS launch Collagen Booster Serum
 An important commercial milestone has been reached for Regenics December 10th with the launch of the ground breaking EQ Collagen Boosting Serum from the Norwegian Direct Selling Company Eqology AS.  
30.11.2018
Protocol from Extraordinary Annual Meeting September 26th 2018
September 26th 2018 Protocol of Extraordinary Annual Meeting September 26th 2018. The Annual Meeting 2017 took place in the Companys office, Karvesvingen. 2, Oslo
29.11.2018
Notification of grant:Divisional EPO patent
Notification of grant: Divisional EPO patent
27.11.2018
Adam Robertson new Chief Scientific Officer in Regenics
 Adam Robertson has today signed up as  Chief Scientific Officer for Regenics AS.  Adam is part of the team that develops cutting  edge skin care and wound healing at Regenics.  Adam...
07.11.2018
Regenics Board Meeting No 4 2018
November 7th 2018
17.09.2018
Bernat Rocarols - R&D Engineer Regenics
   
09.09.2018
Regenics Board Meeting No 3 2018
September 9th 2018
19.08.2018
EPO National validation 2018
EPO Patent validation 
30.06.2018
Regenics Board Meeting No 2 2018
June 13th 2018
28.06.2018
Protocol Annual Meeting 2018
June 28th 2018 Protocoll of Regenics Annual Meeting on June 28th 2018. The Annual Meeting 2018 took place in the Companys office, Karvesvingen. 2, Oslo
19.06.2018
US patent granted June 2018
 
15.06.2018
Upcoming event: 37C Health Meeting Stavanger
Regenics AS attends the 37C "Digitalization in Health" meeting on June 19-20 of June 2018 at Forus Stavanger. CEO Henrik Lund, co-chairs the meeting    
13.06.2018
Regenics AS Annual Report 2017
Regenics post a small positive 2017 result with topline in excess of 0.047 mill NOK. 
13.06.2018
Notice and Protocol of Annual Meeting 2018
June 13th 2018 Notice of Annual Meeting June 28th 2018. The Annual Meeting 2018 will take place at the Companys site Karvesvingen 2. 2, Oslo from 2 pm to 5 pm.

<<  <   Page 2 of 7   >  >>

REGENICS AT SCIENCE EVENTS

June 17-19th 2019

The Smart Patient. Regenics (CEO H.Lund co-chair)

Program 2019

December 15th 2018

DnB Healtcare Conference 2018

 

October 5-6th 2018

Wound Healing and Skin Diseaes, Los Angeles (CEO H.Lund keynote invitation)

June 19th – 20th 2018

Conference Biotech-Medtech-Expo, Stavanger (CEO H.Lund co-chair)

Program (tbd)

 

June 5-6th 2017

Investor Conference Biotech-Medtech, Stavanger (CEO co-chair)

Program (tbd)

March 9th 2017

Roundtable Conference in investing in Biotech, CEO Henrik Lund, moderator for the Event at Stavanger Forum Oslo

Program Roundtable Conference Stavanger

March 8th 2017

War on Cancer Nordics, CEO Henrik Lund in closing panel at the Economist Event in Oslo

Program Economist Event Oslo

December 15th 2016

DnB Healtcare Conference 2016, CMO Christian Clemm provides company update in the ventture session

Regenics presentation

October 19-20-21 2016

Biomarine Convention, CEO Henrik Lund, participating at Convention in Oslo

Program Biomarine Business Conference

October 19th 2016

DnB Next at Oslo Innovation Week, CSO Gry Lønne, presenting Regenics Company update in Oslo

program DNB Next healthcare Regenics presentation

September 25-28 2016

At the 4th Congress on Innovation in Drug Delivery in Antibes, Regenics presented abstract.

Abstract 4th Congress on Innovation in Drug Delivery

October 22-24 2015

Joint Meeting of the European Tissue Repair Society (ETRS) and the Wound Healing Society (WHS), Regenics presented abstract

Abstract 7th ETRS-WHS meeting

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.